, APAC
/Nothing Ahead from Pexels

Asian life insurers maintain strong capitalisation

Singapore Life and Muang Thai Life exhibit some financial leverage, unlike others.

Life insurers in select Asian countries have shown strong capitalisation with financial leverage ratios remaining well below the thresholds set for the insurers' respective IFS Ratings, according to Fitch Ratings.

However, Singapore Life and Muang Thai Life exhibit some financial leverage, unlike others in the peer group.

The company profiles of the insurers in the peer group are rated as ‘Favourable’ to ‘Moderate’ compared to peers in their respective markets. 

Muang Thai Life and Thai Life benefit from strong domestic market franchises, whilst CTF Life, GLHK, Singapore Life, and YF Life operate on a smaller scale.

Profitability across the group is solid, with operating profits supported by gains from mortality and investment returns, as well as a focus on regular premium products. 

Whilst new business growth is expected to continue, factors such as intense competition and rising medical costs may limit improvements in new business value margins in the short term.
Investment portfolios within the group consist primarily of fixed-income securities, with limited exposure to equities.
 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.